These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2316454)
41. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Wilber DJ; Olshansky B; Moran JF; Scanlon PJ Circulation; 1990 Aug; 82(2):350-8. PubMed ID: 2372886 [TBL] [Abstract][Full Text] [Related]
42. Limited predictive value of inducible sustained ventricular tachycardia for future occurrence of spontaneous ventricular tachycardia in patients with coronary artery disease and relatively preserved cardiac function. Matsushita T; Chun S; Liem LB; Friday KJ; Sung RJ J Electrocardiol; 2003 Jul; 36(3):205-11. PubMed ID: 12942482 [TBL] [Abstract][Full Text] [Related]
43. Effect of pacing drive cycle length on induction of sustained monomorphic ventricular tachycardia. Mann DE; Florek RC; Reiter MJ J Electrocardiol; 1992 Jan; 25(1):33-8. PubMed ID: 1735790 [TBL] [Abstract][Full Text] [Related]
44. The long-term prognosis of patients with out-of-hospital cardiac arrest but no inducible ventricular tachycardia. Sager PT; Choudhary R; Leon C; Rahimtoola SH; Bhandari AK Am Heart J; 1990 Dec; 120(6 Pt 1):1334-42. PubMed ID: 2248180 [TBL] [Abstract][Full Text] [Related]
45. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319 [TBL] [Abstract][Full Text] [Related]
46. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease. Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854 [TBL] [Abstract][Full Text] [Related]
47. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability. Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591 [TBL] [Abstract][Full Text] [Related]
48. Determinants of inducibility of ventricular tachycardia. Ortiz M; Almendral J; López-Palop R; Villacastín J; Arenal A Am J Cardiol; 2001 Jun; 87(11):1255-9. PubMed ID: 11377350 [TBL] [Abstract][Full Text] [Related]
49. Inducibility of sustained monomorphic ventricular tachycardia as a prognostic indicator in survivors of recent myocardial infarction: a prospective evaluation in relation to other prognostic variables. Cripps T; Bennett ED; Camm AJ; Ward DE J Am Coll Cardiol; 1989 Aug; 14(2):289-96. PubMed ID: 2754119 [TBL] [Abstract][Full Text] [Related]
50. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease. Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337 [TBL] [Abstract][Full Text] [Related]
52. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications. Klein RC; Machell C J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260 [TBL] [Abstract][Full Text] [Related]
54. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease. Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121 [TBL] [Abstract][Full Text] [Related]
55. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia. Shannon JA; Hammill SC; Gersh BJ Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242 [TBL] [Abstract][Full Text] [Related]
56. Acute blood pressure effects at the onset of supraventricular and ventricular tachycardia. Taneja T; Kadish AH; Parker MA; Goldberger JJ Am J Cardiol; 2002 Dec; 90(12):1294-9. PubMed ID: 12480037 [TBL] [Abstract][Full Text] [Related]
57. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group. Am J Cardiol; 1988 Sep; 62(9):571-5. PubMed ID: 3137797 [TBL] [Abstract][Full Text] [Related]
58. Predictors of inducible sustained ventricular tachyarrhythmias in patients with coronary artery disease. Vorperian VR; Gittelsohn AM; Veltri EP J Am Coll Cardiol; 1989 Mar; 13(3):637-45. PubMed ID: 2918170 [TBL] [Abstract][Full Text] [Related]
59. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. Bourke JP; Richards DA; Ross DL; Wallace EM; McGuire MA; Uther JB J Am Coll Cardiol; 1991 Sep; 18(3):780-8. PubMed ID: 1907984 [TBL] [Abstract][Full Text] [Related]
60. Outcome of patients with nonsustained ventricular tachycardia and severely impaired ventricular function who have negative electrophysiologic studies. Hernández M; Taylor J; Marinchak R; Rials S; Rubin A; Kowey P Am Heart J; 1995 Mar; 129(3):492-6. PubMed ID: 7872177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]